Annual Cash & Cash Equivalents:
$161.55M+$98.59M(+156.59%)Summary
- As of today, MESO annual cash & cash equivalents is $161.55 million, with the most recent change of +$98.59 million (+156.59%) on June 30, 2025.
- During the last 3 years, MESO annual cash & cash equivalents has risen by +$101.10 million (+167.26%).
- MESO annual cash & cash equivalents is now -44.64% below its all-time high of $291.81 million, reached on June 30, 2013.
Performance
MESO Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$161.16M+$123.50M(+327.97%)Summary
- As of today, MESO quarterly cash & cash equivalents is $161.16 million, with the most recent change of +$123.50 million (+327.97%) on June 30, 2025.
- Over the past year, MESO quarterly cash & cash equivalents has increased by +$98.59 million (+157.59%).
- MESO quarterly cash & cash equivalents is now -9.58% below its all-time high of $178.23 million, reached on December 31, 2012.
Performance
MESO Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MESO Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +156.6% | +157.6% |
| 3Y3 Years | +167.3% | +166.6% |
| 5Y5 Years | +24.9% | +24.6% |
MESO Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +167.3% | at high | +328.0% |
| 5Y | 5-Year | at high | +167.3% | at high | +328.0% |
| All-Time | All-Time | -44.6% | +2668.3% | -9.6% | >+9999.0% |
MESO Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | $161.55M(+156.6%) | $161.16M(+328.0%) |
| Dec 2024 | - | $37.66M(-39.8%) |
| Jun 2024 | $62.96M(-11.7%) | $62.56M(-18.9%) |
| Dec 2023 | - | $77.14M(+8.2%) |
| Jun 2023 | $71.32M(+18.0%) | $71.32M(+46.1%) |
| Mar 2023 | - | $48.80M(-27.8%) |
| Dec 2022 | - | $67.62M(-20.9%) |
| Sep 2022 | - | $85.50M(+41.4%) |
| Jun 2022 | $60.45M(-55.8%) | $60.45M(-21.3%) |
| Mar 2022 | - | $76.76M(-19.1%) |
| Dec 2021 | - | $94.85M(-18.2%) |
| Sep 2021 | - | $115.96M(-15.3%) |
| Jun 2021 | $136.88M(+5.8%) | $136.88M(-13.5%) |
| Mar 2021 | - | $158.26M(+104.1%) |
| Dec 2020 | - | $77.53M(-28.3%) |
| Sep 2020 | - | $108.12M(-16.4%) |
| Jun 2020 | $129.33M(+156.5%) | $129.33M(+115.3%) |
| Mar 2020 | - | $60.08M(-26.1%) |
| Dec 2019 | - | $81.35M(+135.5%) |
| Sep 2019 | - | $34.54M(-31.5%) |
| Jun 2019 | $50.43M(+32.7%) | $50.43M(-28.4%) |
| Mar 2019 | - | $70.39M(-8.6%) |
| Dec 2018 | - | $77.02M(+39.7%) |
| Sep 2018 | - | $55.14M(+45.1%) |
| Jun 2018 | $38.01M | $38.01M(-36.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $59.79M(+26.2%) |
| Dec 2017 | - | $47.39M(-24.7%) |
| Sep 2017 | - | $62.94M(+37.5%) |
| Jun 2017 | $45.76M(-43.5%) | $45.76M(-33.8%) |
| Mar 2017 | - | $69.12M(+103.9%) |
| Dec 2016 | - | $33.90M(-43.8%) |
| Sep 2016 | - | $60.35M(-25.4%) |
| Jun 2016 | $80.94M(-26.9%) | $80.94M(-19.0%) |
| Mar 2016 | - | $99.93M(-17.3%) |
| Dec 2015 | - | $120.78M(+55.3%) |
| Sep 2015 | - | $77.76M(+268.1%) |
| Jun 2015 | $110.79M(-40.2%) | $21.13M(+84.8%) |
| Dec 2014 | - | $11.43M(+198.7%) |
| Jun 2014 | $185.37M(-36.5%) | $3.83M(-67.7%) |
| Dec 2013 | - | $11.85M(+50.5%) |
| Jun 2013 | $291.81M(+37.7%) | $7.88M(-95.6%) |
| Dec 2012 | - | $178.23M(>+9900.0%) |
| Jun 2012 | $211.93M(-24.8%) | $1.39M |
| Jun 2011 | $281.81M(+941.0%) | - |
| Jun 2010 | $27.07M(+102.6%) | - |
| Jun 2009 | $13.36M(-1.2%) | - |
| Jun 2008 | $13.53M(+32.2%) | - |
| Jun 2007 | $10.23M(+75.3%) | - |
| Jun 2006 | $5.84M(-49.3%) | - |
| Jun 2005 | $11.51M | - |
FAQ
- What is Mesoblast Limited annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Mesoblast Limited?
- What is Mesoblast Limited annual cash & cash equivalents year-on-year change?
- What is Mesoblast Limited quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Mesoblast Limited?
- What is Mesoblast Limited quarterly cash & cash equivalents year-on-year change?
What is Mesoblast Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of MESO is $161.55M
What is the all-time high annual cash & cash equivalents for Mesoblast Limited?
Mesoblast Limited all-time high annual cash & cash equivalents is $291.81M
What is Mesoblast Limited annual cash & cash equivalents year-on-year change?
Over the past year, MESO annual cash & cash equivalents has changed by +$98.59M (+156.59%)
What is Mesoblast Limited quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MESO is $161.16M
What is the all-time high quarterly cash & cash equivalents for Mesoblast Limited?
Mesoblast Limited all-time high quarterly cash & cash equivalents is $178.23M
What is Mesoblast Limited quarterly cash & cash equivalents year-on-year change?
Over the past year, MESO quarterly cash & cash equivalents has changed by +$98.59M (+157.59%)